Radiochemistry

放射化学

• 批准号: CRC-2015-00091
• 负责人: Price, Eric
• 金额: $ 8.74万
• 依托单位: University of Saskatchewan
• 依托单位国家: 加拿大
• 项目类别: Canada Research Chairs
• 财政年份: 2019
• 资助国家: 加拿大
• 起止时间: 2019-01-01 至 2020-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=693271
• 关键词: Radiochemistry

Two fields of health research that benefit greatly from radioactive pharmaceuticals (radioactive drugs) are cancer and bacterial infections. Radiopharmaceuticals can be used with very sensitive molecular imaging techniques to learn new information about important biological and physiological processes. Radiopharmaceutical agents are routinely used for early detection, staging, and treatment of cancer, and also for imaging bacterial infections. The objective of this Canada Research Chair will be the creation of new radiopharmaceuticals to selectively target a number of unique types of cancer to provide improved and personalized medicine, and to pioneer new radioactive therapeutic agents to treat the emerging threat of multi-drug resistant bacteria.

受益于放射性药物（放射性药物）的两个健康研究领域是癌症和细菌感染。放射性药物可以与非常灵敏的分子成像技术一起使用，以了解有关重要生物和生理过程的新信息。放射性药剂通常用于癌症的早期检测、分期和治疗，也用于细菌感染的成像。这位加拿大研究主席的目标是创造新的放射性药物，选择性地针对一些独特类型的癌症，提供改进和个性化的医疗，并开拓新的放射性治疗剂来治疗多重耐药细菌的新威胁。